These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1990564)
1. Anti-HLA antibody removal in hyperimmunized ESRF patients to allow transplantation. The Collaborative Study Group on Anti-HLA Antibody Removal. Gjörstrup P Transplant Proc; 1991 Feb; 23(1 Pt 1):392-5. PubMed ID: 1990564 [No Abstract] [Full Text] [Related]
2. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294 [TBL] [Abstract][Full Text] [Related]
3. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients. Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536 [No Abstract] [Full Text] [Related]
4. Specific HLA antibody production following renal transplantation. Martin S; Dyer PA; Gokal R; Mallick NP; Johnson RW Transplant Proc; 1987 Feb; 19(1 Pt 1):898. PubMed ID: 3274885 [No Abstract] [Full Text] [Related]
5. Association between long-term kidney graft survival and the presence of pre-transplant cytotoxic anti-HLA and/or non-MHC 'Fc gamma RII blocking' (anti-TLX) alloantibody. Padányi A; Gyódi E; Rajczy K; Perner F; Petrányi GG Clin Transplant; 1996 Oct; 10(5):455-60. PubMed ID: 8930462 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation. Lee PC; Ozawa M Clin Transpl; 2007; ():219-26. PubMed ID: 18642453 [TBL] [Abstract][Full Text] [Related]
7. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss. Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503 [TBL] [Abstract][Full Text] [Related]
8. Prediction of humoral immune responses to HLA through antiidiotypic antibody studies. Reed E; McManus P; Ho E; Benvenisty A; Hardy M; McCabe R; Brensilver J; King DW; Suciu-Foca N Transplant Proc; 1989 Feb; 21(1 Pt 1):708-10. PubMed ID: 2650235 [No Abstract] [Full Text] [Related]
13. Immunological profile of patients awaiting a renal transplant. Díaz I; Sánchez P; Alonso C; Valdés F Clin Transplant; 2004 Oct; 18(5):529-35. PubMed ID: 15344955 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. Jordan SC; Tyan D; Stablein D; McIntosh M; Rose S; Vo A; Toyoda M; Davis C; Shapiro R; Adey D; Milliner D; Graff R; Steiner R; Ciancio G; Sahney S; Light J J Am Soc Nephrol; 2004 Dec; 15(12):3256-62. PubMed ID: 15579530 [TBL] [Abstract][Full Text] [Related]
16. Impact of HCV infection on first cadaveric renal transplantation, a single center experience. Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046 [TBL] [Abstract][Full Text] [Related]
17. Anti-HLA antibodies depletion on protein A-sepharose columns in hyperimmunized patients awaiting renal transplantation. Kriaa F; Rousseau P; Hiesse C; Farahmand H; Brocard JF; Rieu P; Lantz O; Farquet C; Bismuth A; Benoit G Ann Med Interne (Paris); 1992; 143 Suppl 1():39-42. PubMed ID: 1300886 [TBL] [Abstract][Full Text] [Related]
18. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)]. Drannik GN; Driianskaia VE Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199 [No Abstract] [Full Text] [Related]